Dan James Fintel

Phone+1 312 695 0993
Emaildfintelnorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research Interests

Anti-thrombotic therapy, Atrial fibrillation, Cardiac stress testing, Cardiovascular critical care, Coronary heart disease, Ischemic heart disease, Nuclear cardiology

Certifications and Licenses

	Internal Medicine
	Cardiovascular Disease

Training Experience

1982	Residency, Mt. Sinai Hospital
1985	Fellowship, Johns Hopkins Hospital

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Education/Academic qualification

MD, Medicine, Harvard University

… → 1979

Research interests keywords

Cardiology
Cardiovascular Diseases
Cardiovascular Imaging
Lipid Disorders

Fingerprint

Dive into the research topics where Dan James Fintel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

22 Finished

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Kho, A. N. & Fintel, D. J.
Chicago Community Trust, Patient-Centered Outcomes Research Institute
7/1/16 → 9/14/18
Project: Research project
Protocol CACZ885M2301: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients with Elevated hsCRP
Fintel, D. J.
Novartis Pharmaceuticals Corporation
10/11/11 → 10/31/18
Project: Research project
ALERTS (AngeLmed for Early Recognition and Treatment of STEMI) Study
Fintel, D. J.
Angel Medical Systems, Inc.
12/8/10 → 12/8/19
Project: Research project
(TERMINATED)PROT# CV185068: APPRAISE-2 Apixaban for Prevention of Acute Ischemic Safety Events-2 A Phase 3 Randomized Evaluation of the Safety and Efficacy of Apixaban in Patients with a Recent Acute Coronary Syndrome: Pharmacogenetics Blood Sample
Fintel, D. J.
PPD Development, Bristol-Myers Squibb Company
9/18/09 → 9/17/12
Project: Research project
Prot# 34976: A 12-Month Follow-Up Study to Protocol 24779 (A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells
Davidson, C. J., Benzuly, K. H., Fintel, D. J., Flaherty, J. D. & Meyers, S. N.
United BioSource LLC, Baxter Healthcare Corporation
11/26/08 → 11/25/11
Project: Research project

41 Article
9 Review article
1 Chapter

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
the RADIANCE Investigators and Collaborators, May 10 2023, In: JAMA cardiology. 8, 5, JOI230007.
Research output: Contribution to journal › Article › peer-review

Open Access
12 Scopus citations
Comparative effectiveness of aspirin dosing in cardiovascular disease
Jones, W. S., Mulder, H., Wruck, L. M., Pencina, M. J., Kripalani, S., Muñoz, D., Crenshaw, D. L., Effron, M. B., Re, R. N., Gupta, K., David Anderson, R., Pepine, C. J., Handberg, E. M., Manning, B. R., Jain, S. K., Girotra, S., Riley, D., DeWalt, D. A., Whittle, J., Goldberg, Y. H., & 51 othersRoger, V. L., Hess, R., Benziger, C. P., Farrehi, P., Zhou, L., Ford, D. E., Haynes, K., VanWormer, J. J., Knowlton, K. U., Kraschnewski, J. L., Polonsky, T. S., Fintel, D. J., Ahmad, F. S., McClay, J. C., Campbell, J. R., Bell, D. S., Fonarow, G. C., Bradley, S. M., Paranjape, A., Roe, M. T., Robertson, H. R., Curtis, L. H., Sharlow, A. G., Berdan, L. G., Hammill, B. G., Harris, D. F., Qualls, L. G., Marquis-Gravel, G., Modrow, M. F., Marcus, G. M., Carton, T. W., Nauman, E., Waitman, L. R., Kho, A. N., Shenkman, E. A., McTigue, K. M., Kaushal, R., Masoudi, F. A., Antman, E. M., Davidson, D. R., Edgley, K., Merritt, J. G., Brown, L. S., Zemon, D. N., McCormick, T. E., Alikhaani, J. D., Gregoire, K. C., Rothman, R. L., Harrington, R. A., Hernandez, A. F. & Sandu, O. A., May 27 2021, In: New England Journal of Medicine. 384, 21, p. 1981-1990 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
121 Scopus citations
Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction
Outcomes of Beta-blocker Therapy After myocardial INfarction (OBTAIN) Investigators, May 15 2021, In: American Journal of Cardiology. 147, p. 1-7 7 p.
Research output: Contribution to journal › Article › peer-review
7 Scopus citations
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
Marquis-Gravel, G., Roe, M. T., Robertson, H. R., Harrington, R. A., Pencina, M. J., Berdan, L. G., Hammill, B. G., Faulkner, M., Munõz, D., Fonarow, G. C., Nallamothu, B. K., Fintel, D. J., Ford, D. E., Zhou, L., Daugherty, S. E., Nauman, E., Kraschnewski, J., Ahmad, F. S., Benziger, C. P., Haynes, K., & 24 othersMerritt, J. G., Metkus, T., Kripalani, S., Gupta, K., Shah, R. C., McClay, J. C., Re, R. N., Geary, C., Lampert, B. C., Bradley, S. M., Jain, S. K., Seifein, H., Whittle, J., Roger, V. L., Effron, M. B., Alvarado, G., Goldberg, Y. H., Vanwormer, J. L., Girotra, S., Farrehi, P., McTigue, K. M., Rothman, R., Hernandez, A. F. & Jones, W. S., May 2020, In: JAMA cardiology. 5, 5, p. 598-607 10 p.
Research output: Contribution to journal › Article › peer-review
54 Scopus citations
Utility of the ACE Inhibitor Captopril in Mitigating Radiation-Associated Pulmonary Toxicity in Lung Cancer
Small, W., James, J. L., Moore, T. D., Fintel, D. J., Lutz, S. T., Movsas, B., Suntharalingam, M., Garces, Y. I., Ivker, R., Moulder, J., Pugh, S. & Berk, L. B., 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 4, p. 396-401 6 p.
Research output: Contribution to journal › Article › peer-review
24 Scopus citations

Dan James Fintel

Personal profile

Research Interests

Certifications and Licenses

Training Experience

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

Research interests keywords

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)

Protocol CACZ885M2301: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients with Elevated hsCRP

ALERTS (AngeLmed for Early Recognition and Treatment of STEMI) Study

(TERMINATED)PROT# CV185068: APPRAISE-2 Apixaban for Prevention of Acute Ischemic Safety Events-2 A Phase 3 Randomized Evaluation of the Safety and Efficacy of Apixaban in Patients with a Recent Acute Coronary Syndrome: Pharmacogenetics Blood Sample

Prot# 34976: A 12-Month Follow-Up Study to Protocol 24779 (A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

Comparative effectiveness of aspirin dosing in cardiovascular disease

Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction

Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

Utility of the ACE Inhibitor Captopril in Mitigating Radiation-Associated Pulmonary Toxicity in Lung Cancer

Dan James Fintel

Personal profile

Research Interests

Certifications and Licenses

Training Experience

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

Research interests keywords

Fingerprint

Collaborations and top research areas from the last five years

Grants

Research Output